本文選題：過敏性紫癜 + 紫癜性腎炎��； 參考：《瀘州醫(yī)學院》2014年碩士論文

【摘要】：目的：觀察過敏性紫癜嚴重病例血液灌流治療前后的臨床癥狀及血清中胰島素樣生長因子-1、白介素-17含量的變化，探討血液灌流治療過敏性紫癜嚴重病例的療效及其可能機制。方法：收集2012年5月至2014年1月瀘州醫(yī)學院附屬醫(yī)院兒科住院的40例過敏性紫癜嚴重病例，并分為2組：A組、B組，每組各20例。A組僅采取傳統(tǒng)治療（包括抗炎、抗凝、抗過敏等對癥治療）；B組采取血液灌流聯(lián)合傳統(tǒng)治療。同時收集我院門診體檢中心的15例健康兒童作為正常對照組（C組）。觀察并記錄A、B兩組患兒治療前后的腹痛、血便、皮疹、關節(jié)腫痛、血管神經性水腫的變化，以及尿微量白蛋白、尿紅細胞計數(shù)的檢查結果，并統(tǒng)計住院時間。A組在治療前、后采集靜脈全血3ml；B組在血液灌流治療前、第一次、第二次、第三次血液灌流結束時采集靜脈全血3ml；C組僅體檢時采集一次靜脈全血3ml。將上訴標本進行離心，取上清液，采用酶聯(lián)免疫吸附試驗（ELISA）測定每例標本中的胰島素樣生長因子-1、白介素-17的含量，分別比較治療前后各項檢測指標及臨床癥狀在各組間、組內的差異，并對比A、B兩組的住院時間。結果：40例過敏性紫癜嚴重病例在治療后腹痛、血便、皮疹、關節(jié)腫痛、血管神經性水腫均得到緩解，以B組緩解更快，且住院時間縮短；但反映腎臟受累的尿微量白蛋白、尿紅細胞計數(shù)在A、B兩組治療前后的差異無統(tǒng)計學意義。治療前A、B兩組血清中的胰島素樣生長因子-1、白介素-17含量均顯著高于正常對照組， A、B兩組組間差異無統(tǒng)計學意義；治療后A、B組患兒上述細胞因子的含量均較治療前明顯下降，，差異有統(tǒng)計學意義（P 0.01）；而B組在第三次血液灌流結束后的下降較A組更顯著，差異有統(tǒng)計學意義(P 0.01)；A、B兩組在治療后各細胞因子仍高于C組,差異有統(tǒng)計學意義(P 0.01)；B組患兒在三次血液灌流后上述細胞因子較治療前均有下降趨勢，但第一次血液灌流后的下降無統(tǒng)計學意義（P0.05）；第二次、第三次灌流后的下降均有統(tǒng)計學意義（P0.05）；各細胞因子在三次血液灌流結束后的進行兩兩比較，僅第一次與第二次的比較無統(tǒng)計學意義(P0.05)。伴有腎臟受累（尿微量白蛋白及尿紅細胞計數(shù)陽性）的患兒,胰島素樣生長因子-1、白介素-17的含量均較不伴腎臟受累的明顯升高，差異有統(tǒng)計學意義（P 0.01）。上訴指標進行相關性分析提示胰島素樣生長因子-1、白介素-17之間存在正相關關系，有統(tǒng)計學意義(p0.05)；尿微量白蛋白與胰島素樣生長因子-1、白介素-17的含量呈正相關關系,有統(tǒng)計學意義(p0.05)；尿紅細胞計數(shù)與胰島素樣生長因子-1、白介素-17含量呈相關關系，但均無統(tǒng)計學意義（P0.05）。結論：1.過敏性紫癜嚴重病例血清胰島素樣生長因子-1、白介素-17的含量較正常兒童均明顯升高，上述細胞因子可能參與了過敏性紫癜血管炎癥反應的發(fā)生發(fā)展；2.血液灌流聯(lián)合傳統(tǒng)治療對于過敏性紫癜嚴重病例的近期療效明顯優(yōu)于單純傳統(tǒng)治療；3.血液灌流聯(lián)合傳統(tǒng)治療在清除過敏性紫癜嚴重病例血液中的炎癥介質胰島素樣生長因子-1、白介素-17，平衡免疫功能方面優(yōu)于單純傳統(tǒng)治療；4.腎臟受累的過敏性紫癜患兒血清中胰島素樣生長因子-1、白介素-17的含量均較不伴腎臟受累者高；5.血液灌流聯(lián)合傳統(tǒng)治療及單純傳統(tǒng)治療，在近期均未能顯示出腎臟保護作用。血液灌流聯(lián)合傳統(tǒng)治療能否改善紫癜性腎炎的預后，仍需進一步的研究及遠期隨訪。
[Abstract]:Objective: To observe the clinical symptoms, the changes of serum insulin like growth factor -1 (IGF) and the content of il--17 in serum before and after hemoperfusion in severe cases of anaphylactoid purpura, and to explore the effect and possible mechanism of hemoperfusion in the treatment of allergic purpura severe cases. Methods: from May 2012 to January 2014, the children of Affiliated Hospital of Luzhou Medical College were collected. 40 cases of anaphylactoid purpura severe cases in the hospital were divided into 2 groups: group A and group B, 20 cases in each group of.A were treated with traditional treatment (including anti-inflammatory, anticoagulant, antiallergic and other symptomatic treatment); group B was treated with blood perfusion combined with traditional treatment. At the same time, 15 healthy children in the medical center of our hospital were collected as the normal control group (group C). A, B two groups of children with abdominal pain, blood stool, rash, joint swelling and pain, changes in vascular neurodropsy, urine microalbumin, urine red blood cell count examination results, and the time of hospitalization time.A group before the treatment, after the collection of venous blood 3ml; group B before the blood perfusion treatment, the first, second, third blood perfusion ends. The total venous blood 3ml was collected and the C group collected only one vein whole blood 3ml. to centrifuge the appellate specimen and take the supernatant, and use the enzyme linked immunosorbent assay (ELISA) to determine the insulin like growth factor -1 and the content of interleukin -17 in each sample. A, B two groups of hospitalization time. Results: 40 cases of anaphylactoid purpura severe cases of abdominal pain after treatment, blood stool, rash, joint swelling and pain, vascular neuroedema were alleviated, B group remission faster, and hospitalization time shorter; but reflect the kidney involvement of urine microalbumin, urine red blood cell count in the A, B two groups before and after treatment The serum levels of IGF -1 and interleukin -17 in the serum of A and B two before treatment were significantly higher than those in the normal control group, and there was no significant difference between the two groups of A and B. The contents of the cytokines in the A and B group were significantly lower than those before the treatment (P 0.01), while the B group was in the B group. After the third blood perfusion, the decrease was more significant than that in the A group (P 0.01); A, B two groups were still higher than the C group after treatment (P 0.01). The above cytokines in the B group were decreased after three blood perfusion, but the decrease after the first blood perfusion was no longer than before the treatment. Statistical significance (P0.05); second and third times after perfusion were statistically significant (P0.05); each cell factor was compared at the end of the three hemoperfusion, and there was no significant difference between the first and second times (P0.05). The content of ISL like growth factor -1 and interleukin -17 was significantly higher than that of renal involvement, the difference was statistically significant (P 0.01). The correlation analysis of the appeal indicators suggested that there was a positive correlation between insulin like growth factor -1, interleukin -17, and statistically significant (P0.05); urine microalbumin and insulin like growth factor -1 The content of interleukin -17 was positively correlated (P0.05), and the urine red cell count was related to the content of insulin like growth factor -1 and interleukin -17, but there was no statistical significance (P0.05). Conclusion: 1. the serum insulin like growth factor -1 and the content of interleukin -17 in the severe cases of Henoch Schonlein purpura and the content of interleukin -17 are more obvious than those of normal children. The above cytokines may be involved in the development of anaphylactoid purpura vascular inflammation, 2. hemoperfusion combined with traditional treatment is obviously better than traditional treatment for the severe cases of anaphylactoid purpura; 3. hemoperfusion combined with traditional treatment in the removal of inflammatory mediators in the blood of allergic purpura severe cases ISL like growth factor -1, il--17, balanced immune function is superior to simple traditional treatment; 4. the serum levels of IGF -1 and il--17 in children with Henoch Schonlein purpura with renal involvement are higher than those without renal involvement; 5. the combination of traditional and traditional treatment of hemoperfusion can not be shown in the near future. Renal protection. Whether hemoperfusion combined with traditional treatment can improve the prognosis of Henoch Schonlein purpura nephritis still needs further study and long-term follow-up.
【學位授予單位】：瀘州醫(yī)學院
【學位級別】：碩士
【學位授予年份】：2014
【分類號】：R725.5

【參考文獻】

相關期刊論文 前10條

1 鄭雯潔;陳敏廣;陳曉英;楊青;林瑞霞;;兒童紫癜性腎炎巨噬細胞移動抑制因子表達及意義[J];中國當代兒科雜志;2010年02期

2 蔡晉;徐美玉;;不同尿白蛋白水平紫癜性腎炎患兒尿MPC-1水平的變化[J];第三軍醫(yī)大學學報;2010年21期

3 謝凱;李秋;王墨;唐雪梅;王曉剛;;小兒過敏性紫癜血液灌流治療72例分析[J];兒科藥學雜志;2011年02期

4 劉劍鋒;胡擎鵬;馮偉;劉梅梅;;過敏性紫癜患兒尿中單核細胞趨化蛋白-1及轉化生長因子-β_1檢測的意義[J];廣東醫(yī)學;2011年24期

5 茹涼;阿布來提·阿不都哈爾;郭艷芳;;IGF-1及IGFBP-3在過敏性紫癜及紫癜性腎炎患兒臨床檢測中的意義[J];中國當代兒科雜志;2013年11期

6 黃丹琳;吳小川;鄭衛(wèi)民;彭曉杰;何小解;莫雙紅;;紫癜性腎炎患兒腎組織podocalyxin的表達及其與尿足細胞數(shù)的相關分析(英文)[J];中南大學學報(醫(yī)學版);2012年02期

7 范秋霞;王春美;盛光耀;;Th17細胞和白細胞介素-17在兒童過敏性紫癜發(fā)病中作用[J];中華實用診斷與治療雜志;2010年11期

8 楊軍;李成榮;王國兵;黃惠君;祖穎;李永柏;;Th17細胞與CD4~+CD25~+調節(jié)性T細胞在兒童過敏性紫癜發(fā)病機制中的作用[J];臨床兒科雜志;2009年07期

9 周紅霞;梅柏如;趙麗萍;葛婷婷;張林;;血液灌流治療重癥過敏性紫癜17例療效分析[J];臨床兒科雜志;2012年04期

10 王延棟;孫書珍;丁文捷;甄軍暉;;中性粒細胞明膠酶相關運載蛋白在過敏性紫癜患兒中的變化及其臨床意義[J];山東大學學報(醫(yī)學版);2010年02期

本文編號：2030555